These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35989271)

  • 1. Anti-SOX1 Antibody-positive Small-cell Lung Cancer That Triggered Opsoclonus.
    Chiko Y; Sugisaki Y; Miyoshi K; Morichika D; Beika Y; Taniguchi A; Ichihara E; Okada T
    Intern Med; 2023 Mar; 62(6):881-884. PubMed ID: 35989271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic Opsoclonus-myoclonus Syndrome with Anti-Hu and Anti-SOX-1 Antibodies after Immune-checkpoint Inhibitor Treatment Combined with Chemotherapy in a Patient with Small-cell Lung Cancer.
    Arai H; Utsu Y; Horio J; Furukawa S; Kikkawa Y
    Intern Med; 2022; 61(1):71-74. PubMed ID: 34980760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential fluctuating paraneoplastic ocular flutter-opsoclonus-myoclonus syndrome and Lambert-Eaton myasthenic syndrome in small-cell lung cancer.
    Simister RJ; Ng K; Lang B; Beckles M; Chao D; McCabe DJ
    J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):344-6. PubMed ID: 20392978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraneoplastic opsoclonus-myoclonus-ataxia syndrome revealing dual malignancy.
    Nasri A; Kacem I; Jerdak F; Djebara MB; Mejri N; Sidhom Y; Gargouri A; Gouider R
    Neurol Sci; 2016 Oct; 37(10):1723-5. PubMed ID: 27329274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment-refractory paraneoplastic opsoclonus-myoclonus syndrome in a patient with small-cell carcinoma of the lung.
    Alkan A; Cenikli U; Uylaş S; Yılmaz M; Çakır T; Çetinkaya H; Kıran A; Tanrıverdi Ö
    J Oncol Pharm Pract; 2020 Jan; 26(1):209-211. PubMed ID: 30791855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Small cell lung cancer complicated by opsoclonus myoclonus syndrome].
    Iwata T; Yokomura I; Ohsugi S; Uesaka A; Sekiguchi K; Nishio A
    Nihon Kokyuki Gakkai Zasshi; 2009 Nov; 47(11):1046-50. PubMed ID: 19994603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsoclonus-myoclonus syndrome and exaggerated startle response associated with small-cell lung cancer.
    Sotirchos ES; Dorsey ER; Tan IL; Zee DS
    Mov Disord; 2011 Aug; 26(9):1769-70. PubMed ID: 21452255
    [No Abstract]   [Full Text] [Related]  

  • 8. A rare case of Opsoclonus-Myoclonus associated with SCLC.
    Lebeer M; Montagna M; Coito S; Reynders T; Raskin J
    Acta Neurol Belg; 2020 Aug; 120(4):1017-1019. PubMed ID: 32557266
    [No Abstract]   [Full Text] [Related]  

  • 9. Paraneoplastic opsoclonus-myoclonus associated with anti-Hu antibody.
    Hersh B; Dalmau J; Dangond F; Gultekin S; Geller E; Wen PY
    Neurology; 1994 Sep; 44(9):1754-5. PubMed ID: 7936310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer-associated opsoclonus-myoclonus syndrome: a case report.
    Kostoglou A; Vlastos D; Bakalis A; Ghosh D
    World J Surg Oncol; 2021 Nov; 19(1):328. PubMed ID: 34781971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opsoclonus-Ataxia Syndrome in a Patient With Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
    Farina A; Villagrán-García M; Benaiteau M; Lamblin F; Fourier A; Honnorat J; Joubert B
    Neurol Neuroimmunol Neuroinflamm; 2024 Sep; 11(5):e200287. PubMed ID: 39013128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Paraneoplastic opsoclonus-myoclonus syndrome revealing T-cell lymphoma].
    Ducrocq X; Petit J; Taillandier L; Dorvaux V; Anxionnat R; Plénat F; Vespignani H
    Presse Med; 1999 Feb; 28(7):330-3. PubMed ID: 10083874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opsoclonus-myoclonus syndrome associated with pancreatic neuroendocrine tumor: a case report.
    Reinecke R; Reiländer A; Seiler A; Koch C; Voss M
    BMC Neurol; 2022 Dec; 22(1):507. PubMed ID: 36581905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic opsoclonus-myoclonus ataxia associated with non-small-cell lung carcinoma.
    Musunuru K; Kesari S
    J Neurooncol; 2008 Nov; 90(2):213-6. PubMed ID: 18618225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsoclonus-myoclonus syndrome associated with anti Kelch-like protein-11 antibodies in a young female patient without cancer.
    Fonseca E; Varas R; Godoy-Santín J; Valenzuela R; Sandoval P
    J Neuroimmunol; 2021 Jun; 355():577570. PubMed ID: 33862421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opsoclonus-myoclonus syndrome associated with a nasopharyngeal tumor in an adult: a case report.
    Taib BG; Kinshuck AJ; Milburn-McNulty P; Fratalia L; Forsyth L; Husband D; Jones TM; Jacob A
    J Med Case Rep; 2015 Jun; 9():128. PubMed ID: 26033370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-SOX1 antibody-positive paraneoplastic neurological syndrome presenting with Lambert-Eaton myasthenic syndrome and small cell lung cancer: A case report.
    Li C; Wang X; Sun L; Deng H; Han Y; Zheng W
    Thorac Cancer; 2020 Feb; 11(2):465-469. PubMed ID: 31880403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Ri-associated paraneoplastic neurological syndrome: Initial symptom of breast cancer with HER2 overexpression and treatment by dual HER2 blockade.
    Olmez OF; Kinikoglu O; Yilmaz NH; Bilici A; Cubukcu E; Seker M; Cakir T; Yildiz O; Hamdard J
    J Oncol Pharm Pract; 2019 Sep; 25(6):1526-1530. PubMed ID: 30124121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood opsoclonus-myoclonus syndrome: diagnosis and treatment.
    Blaes F; Dharmalingam B
    Expert Rev Neurother; 2016 Jun; 16(6):641-8. PubMed ID: 27095464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineuronal Nuclear Autoantibody Type 1/Anti-Hu-Associated Opsoclonus Myoclonus and Epilepsia Partialis Continua: Case Report and Literature Review.
    Sweeney M; Sweney M; Soldán MM; Clardy SL
    Pediatr Neurol; 2016 Dec; 65():86-89. PubMed ID: 27707529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.